Takenori Niioka

Relationship Among Gefitinib Exposure, Polymorphisms of Its Metabolizing Enzymes and Transporters, and Side Effects in Japanese Patients With Non–Small-Cell Lung Cancer

Hiroyuki Kobayashi, Kazuhiro Sato, Takenori Niioka et al. · Clinical Lung Cancer · 2014 · 60 citations

Medicine, Pharmacokinetics, Pharmacology +17

Comparison of Pharmacokinetics and Pharmacogenetics of Once- and Twice-Daily Tacrolimus in the Early Stage After Renal Transplantation

Takenori Niioka, Shigeru Satoh, H.‐Matsuo Kagaya et al. · Transplantation · 2012 · 60 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Limited Sampling Strategy for Simultaneous Estimation of the Area Under the Concentration-Time Curve of Tacrolimus and Mycophenolic Acid in Adult Renal Transplant Recipients

Masatomo Miura, Shigeru Satoh, Takenori Niioka et al. · Therapeutic Drug Monitoring · 2008 · 53 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

Influence of H2-receptor antagonists and proton pump inhibitors on dasatinib pharmacokinetics in Japanese leukemia patients

Naoto Takahashi, Masatomo Miura, Takenori Niioka et al. · Cancer Chemotherapy and Pharmacology · 2011 · 52 citations

Medicine, Pharmacokinetics, Pharmacology +7

Sensitive determination of omeprazole and its two main metabolites in human plasma by column-switching high-performance liquid chromatography: Application to pharmacokinetic study in relation to CYP2C19 genotypes

Masao Shimizu, T. Uno, Takenori Niioka et al. · Journal of Chromatography B · 2006 · 44 citations

Pharmacy, Pharmacokinetics, Pharmacology +12